271 related articles for article (PubMed ID: 1881737)
1. Social acceptability of methylphenidate and behavior modification for treating attention deficit hyperactivity disorder.
Liu C; Robin AL; Brenner S; Eastman J
Pediatrics; 1991 Sep; 88(3):560-5. PubMed ID: 1881737
[TBL] [Abstract][Full Text] [Related]
2. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
3. Acceptability of behavioral and pharmacological treatments for attention-deficit/hyperactivity disorder: relations to child and parent characteristics.
Johnston C; Hommersen P; Seipp C
Behav Ther; 2008 Mar; 39(1):22-32. PubMed ID: 18328867
[TBL] [Abstract][Full Text] [Related]
4. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers.
Power TJ; Hess LE; Bennett DS
J Dev Behav Pediatr; 1995 Aug; 16(4):238-43. PubMed ID: 7593658
[TBL] [Abstract][Full Text] [Related]
5. Children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment: impact on parental practices.
Hechtman L; Abikoff H; Klein RG; Greenfield B; Etcovitch J; Cousins L; Fleiss K; Weiss M; Pollack S
J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):830-8. PubMed ID: 15213584
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: results from a Taiwanese sample.
Yang P; Hsu HY; Chiou SS; Chao MC
Aust N Z J Psychiatry; 2007 Dec; 41(12):998-1004. PubMed ID: 17999272
[TBL] [Abstract][Full Text] [Related]
7. Treatment effectiveness of combined medication/behavioural treatment with chinese ADHD children in routine practice.
So CY; Leung PW; Hung SF
Behav Res Ther; 2008 Sep; 46(9):983-92. PubMed ID: 18692170
[TBL] [Abstract][Full Text] [Related]
8. The role of treatment acceptability in the initiation of treatment for ADHD.
Krain AL; Kendall PC; Power TJ
J Atten Disord; 2005 Nov; 9(2):425-34. PubMed ID: 16371665
[TBL] [Abstract][Full Text] [Related]
9. Social functioning in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment.
Abikoff H; Hechtman L; Klein RG; Gallagher R; Fleiss K; Etcovitch J; Cousins L; Greenfield B; Martin D; Pollack S
J Am Acad Child Adolesc Psychiatry; 2004 Jul; 43(7):820-9. PubMed ID: 15213583
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
11. Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD.
Flapper BC; Schoemaker MM
Dev Med Child Neurol; 2008 Apr; 50(4):294-9. PubMed ID: 18352997
[TBL] [Abstract][Full Text] [Related]
12. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents' and children's perspectives.
Berger I; Dor T; Nevo Y; Goldzweig G
J Child Neurol; 2008 Sep; 23(9):1036-42. PubMed ID: 18487521
[TBL] [Abstract][Full Text] [Related]
14. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
[TBL] [Abstract][Full Text] [Related]
15. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
16. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
17. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study.
Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH
Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069
[TBL] [Abstract][Full Text] [Related]
18. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
Gadow KD; Nolan E; Sprafkin J; Sverd J
J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
[TBL] [Abstract][Full Text] [Related]
19. Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.
Polanczyk G; Zeni C; Genro JP; Guimarães AP; Roman T; Hutz MH; Rohde LA
Arch Gen Psychiatry; 2007 Feb; 64(2):218-24. PubMed ID: 17283289
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylphenidate and behavior modification on the social and academic behavior of children with disruptive behavior disorders: the moderating role of callous/unemotional traits.
Waschbusch DA; Carrey NJ; Willoughby MT; King S; Andrade BF
J Clin Child Adolesc Psychol; 2007; 36(4):629-44. PubMed ID: 18088220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
